津巴布韦因质量缺陷召回阿兹胺剂批. Zimbabwe recalls Azithromycin batch due to quality defects.

津巴布韦药品控制局因可能降低该药物的有效性而召回了一批阿兹胺片. The Medicines Control Authority of Zimbabwe has recalled a batch of Azithromycin tablets due to quality defects that may reduce the drug's effectiveness. 由于稳定性测试显示该药可能不能正确释放活性成分,因此决定召回产品. The recall, ordered after stability tests revealed the medicine may not release its active ingredient properly, affects a specific batch produced by Indoco Remedies. 当局已指示分销商和公众将受影响的药物返回, 如果他们使用过它,请咨询医疗保健提供者. Authorities have directed distributors and the public to return the affected medication and consult healthcare providers if they have used it.